THE problem of wasting ascites occurring in patients with cirrhosis of the liver is unsolved — both the pathogenesis of the ascites and its reliable cure. Recent observations have indicated the ...

HERNIA is known to be more frequent among patients with cirrhosis of the liver, especially with ascites, than among those without liver disease. Chapman et al. 1 reported a rate of 10 per cent in 58 ...

Investigators assessed the long-term outcomes of patients with cirrhosis and ascites switched from treatment with propranolol to carvedilol. Patients with cirrhosis and ascites had improved renal ...

This 29-year-old man developed new-onset ascites while in hospital. The patient has HIV infection, first diagnosed in 1994. He has been poorly compliant with his highly active antiretroviral therapy ...

Splenomegaly resulting from portal hypertension can be caused by cirrhosis, hepatic venous outflow tract obstruction and extrahepatic portal vein obstruction. Both cirrhosis and hepatic venous outflow ...

Most patients with ascites caused by liver cirrhosis are treated with diuretics in addition to dietary sodium restriction. This creates a negative nitrogen balance and promotes mobilization of ascites ...

We performed an RIC PBSCT from an HLA-identical brother in a 52-year-old woman with CLL Rai IV. Conditioning consisted of fludarabine, busulphan and ATG. Cyclosporin A (CsA) as GVHD prophylaxis was ...

SANTA MONICA, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for the treatment of liver ...

Association between a validated symptom assessment tool and nurse clinical impression in patients with cancer admitted to a palliative care unit. This is an ASCO Meeting Abstract from the 2011 ASCO ...

VEGF pathway therapy: Resampling positive phase III data to assess phase II trial designs and endpoints. Background: Malignant ascites (MA) is a symptom of late-stage tumor disease and associated with ...

FRANKLIN LAKES, N.J., June 23, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance from ...